phase readout
saveNCT00093353: N2003-01: Irinotecan, Temozolomide, and Cefixime in Treating Young Patients With Recurrent or Resistant Neuroblastoma
COMPLETEDupdated 56m ago
community read0 votes
Sponsor: New Approaches to Neuroblastoma Therapy Consortium. Phase: PHASE1. Conditions: Diarrhea, Drug/Agent Toxicity by Tissue/Organ, Neuroblastoma
view source ↗
comments(0)
5-min edit window · permanent after that